ArticleJournal of medicinal chemistry2022

Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding Pose.

Lingtian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.